ONCYRegulatory•prnewswire•
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Sentiment:Positive (68)
Summary
(NASDAQ:ONCY) Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 2, 2025 /PRNewswire/ -- Cancer innovation is reaching new heights as the FDA approved breakthrough therapies for aggressive malignancies, including Modeyso for deadly brain tumors, while...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by prnewswire